Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma

Survivin as a Diagnostic and Therapeutic Marker for Thyroid Cancer

(2019) Mohammad-Reza Mahmoudian-Sani et al.   PATHOLOGY RESEARCH AND PRACTICE

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

(2019) Ying Jiang et al.   NATURE

Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population

(2019) Xing Liu et al.   LIVER INTERNATIONAL

A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing

(2019) Guojun Chen et al.   Nature Nanotechnology

Co-delivery of paclitaxel and survivin siRNA with cationic liposome for lung cancer therapy

(2019) Chuanmin Zhang et al.   COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS

Unlockable Nanocomplexes with Self-Accelerating Nucleic Acid Release for Effective Staged Gene Therapy of Cardiovascular Diseases

(2018) Jing-Jun Nie et al.   ADVANCED MATERIALS

Versatile types of hydroxyl-rich polycationic systems via O -heterocyclic ring-opening reactions: From strategic design to nucleic acid delivery applications

(2018) Fu-Jian Xu   PROGRESS IN POLYMER SCIENCE

Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids

(2018) Yu Qi et al.   Small

Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma

(2018) Michael J Flynn et al.   HEPATOLOGY

Therapeutic strategies involving survivin inhibition in cancer

(2018) David Martínez‐García et al.   MEDICINAL RESEARCH REVIEWS

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

(2017) et al.   JAMA Oncology

Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice

(2016) Ling Li et al.   ACS Nano

Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy

(2016) Shengpeng Wang et al.   JOURNAL OF CONTROLLED RELEASE

Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies

(2016) Xun Chen et al.   Journal of Cancer

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Therapeutic genome editing: prospects and challenges

(2015) David Benjamin Turitz Cox et al.   NATURE MEDICINE

Delivery of Mitogen-Activated Protein Kinase Inhibitor for Hepatocellular Carcinoma Stem Cell Therapy

(2014) Yang Liu et al.   ACS Applied Materials & Interfaces

pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma

(2014) Daishun Ling et al.   ACS Nano

Non-viral vectors for gene-based therapy

(2014) Hao Yin et al.   NATURE REVIEWS GENETICS

Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib

(2012) Anja Lachenmayer et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Redox-Active Polymer Microcapsules for the Delivery of a Survivin-Specific siRNA in Prostate Cancer Cells

(2011) Alisa L. Becker et al.   ACS Nano

Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression

(2011) Young-Sun Kim et al.   BIOCHEMICAL PHARMACOLOGY

Survivin Silencing as a Promising Strategy To Enhance the Sensitivity of Cancer Cells to Chemotherapeutic Agents

(2011) S. Trabulo et al.   MOLECULAR PHARMACEUTICS

Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery

(2009) Laura Beretta   CANCER LETTERS

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE